Caritas Neuro Solutions has signed a landmark partnership agreement with Mumbai, India-based digitally driven organisation Innvocept Solutions, enabling expansion of the company as a global player.
The move enables us to run full service pharmaceutical and biotechnology clinical trials across the globe with staff based throughout India, Malaysia, Sri Lanka and Singapore in addition to existing capabilities throughout Europe.
Innvocept was set up with a similar aim of providing small and medium-sized enterprises (SMEs) with cost effective solutions for drug development, to help promising new therapies can reach patients in a timely manner.
“I am delighted that we have managed to make this work as both companies share the same values of compassion, collaboration and integrity,” said Caritas chief executive Leigh Fell of the alliance. “Our skill sets complement each other and together we’ll be able to make a much more significant impact and really change lives.”
Life science has a strong history of success in Scotland and remains one of the country’s leading sectors, employing around 40,000 people. International collaborations such as this Asia-pacific deal provide significant contribution towards the Life Science Strategy for Scotland, which aims to grow the sector to £8 billion by 2025.